Gamida Cell Gamida Cell develops stem cell therapy technologies and products for the treatment of blood cancers, autoimmune and metabolic diseases. | ||||
Founding Date | Founding Date 1998 | Founding Date 1997 | Founding Date 2009 | Founding Date 2013 |
Type | Type Public | Type Private | Type Public | Type Private |
Tags | ||||
Locations | Locations Boston, US HQ Jerusalem, IL | Locations Laval, CA HQ | Locations Lund, SE HQ Lund, SE Lund, SE | Locations South San Francisco, US HQ |
Employees | Employees 143175% increase | Employees 21 | Employees 15 | Employees 12 |
Financial | ||||
Revenue (est.) | Revenue (est.) $1.8m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) kr78k (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods $1.5m (FY, 2023) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $330k (FY, 2023) | Gross profit N/A | Gross profit kr1.8m (FY, 2023) | Gross profit N/A |
Net income | Net income ($63m) (FY, 2023) | Net income N/A | Net income (kr54.1m) (FY, 2023) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 128.3m | Total funding raised N/A | Total funding raised $ 934.5k | Total funding raised N/A |